Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?
Nose Y, Yamashita K, Takeoka T, Momose K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Shiraishi O, Miyata H, Yasuda T, Yano M, Eguchi H, Doki Y. Nose Y, et al. Among authors: yamamoto k. Ann Surg Oncol. 2022 Jun;29(6):3613-3614. doi: 10.1245/s10434-022-11437-z. Epub 2022 Feb 15. Ann Surg Oncol. 2022. PMID: 35166955 No abstract available.
A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT.
Takiguchi S, Yamamoto K, Hirao M, Imamura H, Fujita J, Yano M, Kobayashi K, Kimura Y, Kurokawa Y, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Takiguchi S, et al. Among authors: yamamoto k. Gastric Cancer. 2012 Apr;15(2):198-205. doi: 10.1007/s10120-011-0098-1. Epub 2011 Oct 13. Gastric Cancer. 2012. PMID: 21993852 Clinical Trial.
Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.
Hiura Y, Takiguchi S, Yamamoto K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Fujiwara Y, Mori M, Kangawa K, Doki Y. Hiura Y, et al. Among authors: yamamoto k. Cancer. 2012 Oct 1;118(19):4785-94. doi: 10.1002/cncr.27430. Epub 2012 Jan 26. Cancer. 2012. PMID: 22282373 Free article. Clinical Trial.
15,611 results
You have reached the last available page of results. Please see the User Guide for more information.